Taken together, this study suggests the anti-lipogenic effect of ISL1 and KDM6B in NAFLD, which is achieved by KDM6B-catalyzed demethylation in the promoter region of SNAI1. The gene discussed is SNAI1; the disease is metabolic dysfunction-associated steatotic liver disease.